Your browser doesn't support javascript.
loading
Reactive oxygen species mediated apoptotic death of colon cancer cells: therapeutic potential of plant derived alkaloids.
Nelson, Vinod K; Nuli, Mohana Vamsi; Mastanaiah, Juturu; Saleem T S, Mohamed; Birudala, Geetha; Jamous, Yahya F; Alshargi, Omar; Kotha, Kranthi Kumar; Sudhan, Hari Hara; Mani, Ravishankar Ram; Muthumanickam, Alagusundaram; Niranjan, Divya; Jain, Nem Kumar; Agrawal, Ankur; Jadon, Arvind Singh; Mayasa, Vinyas; Jha, Niraj Kumar; Kolesarova, Adriana; Slama, Petr; Roychoudhury, Shubhadeep.
Affiliation
  • Nelson VK; Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, India.
  • Nuli MV; Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, India.
  • Mastanaiah J; Department of Pharmacology, Balaji College of Pharmacy, Anantapur, India.
  • Saleem T S M; College of Pharmacy, Riyadh ELM University, Riyadh, Saudi Arabia.
  • Birudala G; Faculty of Pharmacy, Dr. M.G.R. Educational and Research Institute, Chennai, India.
  • Jamous YF; Vaccines and Bioprocessing Centre, King Abdulaziz City for Science and Technology (KACST), Riyadh, Saudi Arabia.
  • Alshargi O; College of Pharmacy, Riyadh ELM University, Riyadh, Saudi Arabia.
  • Kotha KK; Department of Pharmaceutics, College of Pharmaceutical Sciences, Dayananda Sagar University, Bengaluru, India.
  • Sudhan HH; Raghavendra Institute of Pharmaceutical Education and Research, Anantapur, India.
  • Mani RR; Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia.
  • Muthumanickam A; School of Pharmacy, ITM University, Gwalior, India.
  • Niranjan D; School of Pharmacy, ITM University, Gwalior, India.
  • Jain NK; School of Pharmacy, ITM University, Gwalior, India.
  • Agrawal A; School of Pharmacy, ITM University, Gwalior, India.
  • Jadon AS; Amity Institute of Pharmacy, Amity University, Gwalior, India.
  • Mayasa V; GITAM School of Pharmacy, GITAM University Hyderabad Campus, Rudraram, India.
  • Jha NK; Department of Biotechnology, School of Engineering and Technology, Sharda University, Greater Noida, India.
  • Kolesarova A; Department of Biotechnology, School of Applied & Life Sciences (SALS), Uttaranchal University, Dehradun, India.
  • Slama P; School of Bioengineering & Biosciences, Lovely Professional University, Phagwara, India.
  • Roychoudhury S; Department of Biotechnology Engineering and Food Technology, Chandigarh University, Mohali, India.
Front Endocrinol (Lausanne) ; 14: 1201198, 2023.
Article in En | MEDLINE | ID: mdl-37560308
Colorectal cancer (CRC) is one of the most deaths causing diseases worldwide. Several risk factors including hormones like insulin and insulin like growth factors (e.g., IGF-1) have been considered responsible for growth and progression of colon cancer. Though there is a huge advancement in the available screening as well as treatment techniques for CRC. There is no significant decrease in the mortality of cancer patients. Moreover, the current treatment approaches for CRC are associated with serious challenges like drug resistance and cancer re-growth. Given the severity of the disease, there is an urgent need for novel therapeutic agents with ideal characteristics. Several pieces of evidence suggested that natural products, specifically medicinal plants, and derived phytochemicals may serve as potential sources for novel drug discovery for various diseases including cancer. On the other hand, cancer cells like colon cancer require a high basal level of reactive oxygen species (ROS) to maintain its own cellular functions. However, excess production of intracellular ROS leads to cancer cell death via disturbing cellular redox homeostasis. Therefore, medicinal plants and derived phytocompounds that can enhance the intracellular ROS and induce apoptotic cell death in cancer cells via modulating various molecular targets including IGF-1 could be potential therapeutic agents. Alkaloids form a major class of such phytoconstituents that can play a key role in cancer prevention. Moreover, several preclinical and clinical studies have also evidenced that these compounds show potent anti-colon cancer effects and exhibit negligible toxicity towards the normal cells. Hence, the present evidence-based study aimed to provide an update on various alkaloids that have been reported to induce ROS-mediated apoptosis in colon cancer cells via targeting various cellular components including hormones and growth factors, which play a role in metastasis, angiogenesis, proliferation, and invasion. This study also provides an individual account on each such alkaloid that underwent clinical trials either alone or in combination with other clinical drugs. In addition, various classes of phytochemicals that induce ROS-mediated cell death in different kinds of cancers including colon cancer are discussed.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms / Alkaloids Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: India Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colonic Neoplasms / Alkaloids Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: India Country of publication: Switzerland